Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán, shared a post by Oscar Arrieta, Professor and Chief of the Section of Thoracic Medical Oncology at The National Cancer Institute (Mexico), on Twitter, adding:
“Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population:
– We need to work to improve patient outcomes.”
Quoting Oscar Arrieta‘s post:
“Lack of access to innovative treatments dramatically affects survival. Greater access to immunotherapy treatment is necessary for patients with renal cell cancer. Great collaborative work of Mexican oncologists led by Maite Bourlon and Dra. Nora Sobrevilla. Congratulations for showing these results.”
For more details click here.
Source: Maite Bourlon/Twitter and Oscar Arrieta/twitter